+31 (0)24 3666478info@tropIQ.nl
Skip to navigation Skip to content TROPIQ
Navigation
  • HOME
  • ABOUT US
  • OUR TECHNOLOGY
  • PATHOGENS AND VECTORS
  • NEWS
  • PUBLICATIONS
  • CONTACT
  • HOME
  • ABOUT US
  • OUR TECHNOLOGY
  • PATHOGENS AND VECTORS
  • NEWS
  • PUBLICATIONS
  • CONTACT

TropIQ staff co-authors publication on novel antimalarial compound

October 4, 2016.

TropIQ staff co-author the study ‘Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling‘ published in PloS Medicine today.

Post navigation

← Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors.  →

TROPIQ Health Sciences

Transistorweg 5-C02
6534 AT Nijmegen
The Netherlands

T +31 (0)24 3666478
Send an email

© TropIQ 2017 -

On this website:

  • HOME
  • ABOUT US
  • OUR TECHNOLOGY
  • PATHOGENS AND VECTORS
  • NEWS
  • PUBLICATIONS
  • CONTACT
Webdesign GRAPHX 66